These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1273 related items for PubMed ID: 22698490
1. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. Hsu JC, Solomon SD, Bourgoun M, McNitt S, Goldenberg I, Klein H, Moss AJ, Foster E, MADIT-CRT Executive Committee. J Am Coll Cardiol; 2012 Jun 19; 59(25):2366-73. PubMed ID: 22698490 [Abstract] [Full Text] [Related]
2. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. Ruwald MH, Solomon SD, Foster E, Kutyifa V, Ruwald AC, Sherazi S, McNitt S, Jons C, Moss AJ, Zareba W. Circulation; 2014 Dec 23; 130(25):2278-86. PubMed ID: 25301831 [Abstract] [Full Text] [Related]
3. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy. Biton Y, Kutyifa V, Cygankiewicz I, Goldenberg I, Klein H, McNitt S, Polonsky B, Ruwald AC, Ruwald MH, Moss AJ, Zareba W. Circ Heart Fail; 2016 Feb 23; 9(2):e002667. PubMed ID: 26823498 [Abstract] [Full Text] [Related]
4. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy). Ruwald MH, Ruwald AC, Jons C, Alexis J, McNitt S, Zareba W, Moss AJ. J Am Coll Cardiol; 2013 Apr 09; 61(14):1518-26. PubMed ID: 23500269 [Abstract] [Full Text] [Related]
5. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT). Martin DT, McNitt S, Nesto RW, Rutter MK, Moss AJ. Circ Heart Fail; 2011 May 09; 4(3):332-8. PubMed ID: 21350054 [Abstract] [Full Text] [Related]
13. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT). Goldenberg I, Moss AJ, Hall WJ, Foster E, Goldberger JJ, Santucci P, Shinn T, Solomon S, Steinberg JS, Wilber D, Barsheshet A, McNitt S, Zareba W, Klein H, MADIT-CRT Executive Committee. Circulation; 2011 Oct 04; 124(14):1527-36. PubMed ID: 21900084 [Abstract] [Full Text] [Related]
14. The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). Kutyifa V, Kloppe A, Zareba W, Solomon SD, McNitt S, Polonsky S, Barsheshet A, Merkely B, Lemke B, Nagy VK, Moss AJ, Goldenberg I. J Am Coll Cardiol; 2013 Mar 05; 61(9):936-44. PubMed ID: 23449428 [Abstract] [Full Text] [Related]